Cargando…
Long-lasting neutralizing antibody responses in SARS-CoV-2 seropositive individuals are robustly boosted by immunization with the CoronaVac and BNT162b2 vaccines
The durability of circulating neutralizing antibody (nAb) responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and their boosting by vaccination remains to be defined. We show that outpatient and hospitalized SARS-CoV-2 seropositive individuals mount a robust neutraliz...
Autores principales: | Muena, Nicolás A., García-Salum, Tamara, Pardo-Roa, Catalina, Serrano, Eileen F., Levican, Jorge, Avendaño, María José, Almonacid, Leonardo I., Valenzuela, Gonzalo, Poblete, Estefany, Strohmeier, Shirin, Salinas, Erick, Haslwanter, Denise, Dieterle, Maria Eugenia, Jangra, Rohit K., Chandran, Kartik, González, Claudia, Riquelme, Arnoldo, Krammer, Florian, Tischler, Nicole D., Medina, Rafael A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142662/ https://www.ncbi.nlm.nih.gov/pubmed/34031662 http://dx.doi.org/10.1101/2021.05.17.21257197 |
Ejemplares similares
-
Induction of SARS-CoV-2 neutralizing antibodies by CoronaVac and BNT162b2 vaccines in naïve and previously infected individuals
por: Muena, Nicolás A., et al.
Publicado: (2022) -
Immunogenicity of Mix-and-Match CoronaVac/BNT162b2 Regimen versus Homologous CoronaVac/CoronaVac Vaccination: A Single-Blinded, Randomized, Parallel Group Superiority Trial
por: Samoud, Samar, et al.
Publicado: (2023) -
CoronaVac or BNT162b2 Vaccine as a Third Dose
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022) -
Vaccine effectiveness of heterologous CoronaVac plus BNT162b2 in Brazil
por: Cerqueira-Silva, Thiago, et al.
Publicado: (2022) -
Effectiveness of the BNT162b2 and the CoronaVac vaccines and boosters in healthcare workers
por: Çulpan, Hazal Cansu, et al.
Publicado: (2023)